bioRxiv Science⌕ Search

Biology subjects

Ano Bom, A. P. D.

Publications and source records attributed to Ano Bom, A. P. D..

2 recordsLinked to original sources

The emergence of new lineages of the Monkeypox virus could affect the 2022 outbreak.

Human Mpox is a highly contagious viral disease caused by Mpox virus, currently causing outbreaks in various regions of the world and considered a global public health problem. Understanding how the virus adapts or transfers to a new host species is crucial for effective prevention and treatment of viral infections. A comprehensive analysis of 1,318 accessible Mpox genomes was conducted to assess potential phenotypic effects, incorporating the examination of pseudogenes, gene duplication and deletion, as well as sequences obtained from the 2022 outbreak. This study we analyzed the genomic sequences of Mpox viruses from different clades and found that only a small percentage of proteins were conserved across the analyzed clades, with many proteins exhibiting various mutations, indicating the potential correlation between lineage or clade and variations in the pathology of human Mpox disease. The study highlights the importance of analyzing aligned regions in viral genomes to understand the evolution of the virus and the impact of structural changes on protein functions. In brief, further investigations are required to establish a correlation between the effects of these genetic modifications and the novel transmission pathways, average age, clinical manifestations, and symptoms observed in the ongoing outbreak.

microbiology↗

In Vitro Inhibition of SARS-CoV-2 Infection by Bovine Lactoferrin

Since its emergence in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been posing a serious threat to public health worldwide as the causative agent of coronavirus disease 2019 (COVID-19). Now distributed in a pandemic pattern, this disease still lacks an effective drug treatment with low toxicity, leading pharmaceutical companies and research labs to work against time to find a candidate molecule to efficiently treat the affected patients. Due to the well-known broad-spectrum antimicrobial activity of the lactoferrin protein, we sought to verify whether its bovine form (bLf) would also be effective in vitro against SARS-CoV-2. Using an antiviral assay based on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we found that bLf reduced progeny virus yield by up to [~]84,6% in African green monkey kidney epithelial cells (Vero E6) and [~]68,6% in adenocarcinomic human alveolar basal epithelial cells (A549) at 1 mg/mL, a concentration previously shown to have low cytotoxicity. Therefore, our preliminary data suggest that bLf has the potential to constitute a biochemical approach to fight the new coronavirus pandemic.

microbiology↗